Prenatal exposure to substance of abuse: A worldwide problem

Environment International

Volumn 54, Issue , 2013, Pages 141-163

  Narkowicz, Sylwia ^a   Płotka, Justyna ^a   Polkowska, Zaneta ^a   Biziuk, Marek ^a   Namieśnik, Jacek ^a  

^a GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Abused substance; Alcohol; Biological materials; Illicit drugs; Tobacco smoke; Xenobiotic

Indexed keywords

ALCOHOLS; CHROMATOGRAPHIC ANALYSIS; DRUG PRODUCTS;

ABUSED DRUGS; ABUSED SUBSTANCE; BIOANALYTICAL METHODS; BIOLOGICAL SPECIMENS; CHROMATOGRAPHIC METHODS; COST/BENEFIT; DRUG TESTING; ILLICIT DRUG; INTRAUTERINE GROWTH RESTRICTION; PRENATAL EXPOSURE; PRETERM LABOR; PUBLIC HEALTH ISSUES; SCREENING METHODS; SEXUALLY TRANSMITTED INFECTIONS; SINUS INFECTION; SPECIFIC TIME; SUBSTANCE ABUSE; SUDDEN INFANT DEATH SYNDROMES; TIME WINDOWS; TOBACCO SMOKE; URINARY TRACT INFECTIONS; XENOBIOTIC;

BIOLOGICAL MATERIALS;

ALCOHOL; AMPHETAMINE DERIVATIVE; BIOLOGICAL MARKER; CANNABIS; COCAINE; CYANIDE; ILLICIT DRUG; METHAMPHETAMINE; NICOTINE; OPIATE; TOBACCO SMOKE;

ACCURACY ASSESSMENT; BIOMARKER; CHILD HEALTH; DRUG USER; HEALTH RISK; INFANT MORTALITY; MATERNAL HEALTH; MEDICAL GEOGRAPHY; NUTRITIONAL STATUS; PREGNANCY; PUBLIC HEALTH; SMOKING; XENOBIOTICS;

ALCOHOLISM; ANALYTIC METHOD; ANEMIA; ARTICLE; ASTHMA; ATTENTION DISTURBANCE; BEHAVIOR DISORDER; BIOTRANSFORMATION; CHILD DEVELOPMENT; CHILDHOOD; COLORIMETRY; COST BENEFIT ANALYSIS; DELIVERY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG DEPENDENCE; DYSMENORRHEA; EAR INFECTION; FETAL ALCOHOL SYNDROME; FETOPLACENTAL UNIT; FETUS DISEASE; FLUOROMETRY; HEPATITIS; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INFERTILITY; INTRAUTERINE GROWTH RETARDATION; IRRITABILITY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MALNUTRITION; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; PARANASAL SINUS DISEASE; PLACENTAL TRANSFER; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANT WOMAN; PREMATURE LABOR; PREMATURITY; PRENATAL CARE; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PUBLIC HEALTH; RESPIRATORY TRACT INFECTION; SENSITIVITY AND SPECIFICITY; SEXUALLY TRANSMITTED DISEASE; SMOKING; SOLID PHASE MICROEXTRACTION; SOLUTIO PLACENTAE; SPONTANEOUS ABORTION; STILLBIRTH; SUDDEN INFANT DEATH SYNDROME; TOBACCO DEPENDENCE; URINALYSIS; URINARY TRACT INFECTION; WITHDRAWAL SYNDROME; XENOBIOTIC METABOLISM;

EID: 84874358689     PISSN: 01604120     EISSN: 18736750     Source Type: Journal    
DOI: 10.1016/j.envint.2013.01.011     Document Type: Article

References (87)

1. Albrecht J., Lindsay B., Terplan M. Effect of waiting time on substance abuse treatment completion in pregnant women. J Subst Abuse Treat 2011, 41:71-77.
2. Bar-Oz B., Klein J., Karaskov T., Koren G. Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse. Arch Dis Child Fetal Neonatal Ed 2003, 88:98-100.
3. Barnes A.J., Brunet B.R., Choo R.E., Mura P., Johnson R.E., Jones H.E., et al. Excretion of methadone in sweat of pregnant women throughout gestation after controlled methadone administration. Ther Drug Monit 2010, 32:497-503.
4. Berlin I., Heilbronner C., Georgieu S., Meier C., Spreux-Varoguaux O. Newborns' cord blood plasma cotinine concentrations are similar to that of their delivering smoking mothers. Drug Alcohol Depend 2010, 107:250-252.
5. Bhuvaneswar C.G., Chang G., Epstein L.A., Stern T.A. Cocaine and opioid use during pregnancy: prevalence and management. Prim Care Companion J Clin Psychiatry 2008, 10:59-65.
6. Blount B.C., Valentin-Blasini L. Analysis of perchlorate, thiocyanate, nitrate and iodide in human amniotic fluid using ion chromatography and electrospray tandem mass spectrometry. Anal Chim Acta 2006, 567:87-93.
7. Borgerdinga M., Klusb H. Analysis of complex mixtures - cigarette smoke. Exp Toxicol Pathol 2005, 57:43-73.
8. Burnat P., Le Brumant-Payen C. Intoxication par la cocaïne. Lyon Pharm 1992, 43:149-156.
9. Catanzarite V.A., Stein D.A. 'Crystal' and pregnancy - methamphetamine-associated maternal deaths. West J Med 1995, 162:454-457.
10. Chambers C.D., Kavteladze L., Joutchenko L., Bakhireva L.N., Jones K.L. Alcohol consumption patterns among pregnant women in the Moscow region of the Russian Federation. Alcohol 2006, 38:133-137.
11. Chen C., Cho S.I., Damokosh A.I., Chen D., Li G., Wang X., et al. Prospective study of exposure to environmental tobacco smoke and dysmenorrhea. Environ Health Perspect 2000, 108:1019-1022.
12. Day N.L., Richardson G.A. Prenatal marijuana use: epidemiology, methodologic issues, and infant outcome. Clin Perinatol 1991, 18:77-91.
13. De Oliveira C.D.R., Roehsig M., De Almeida R.M., Rocha W.L., Yonamine M. Recent advances in chromatographic methods to detect drugs of abuse in alternative biological matrices. Curr Pharm Anal 2007, 3:95-109.
14. Dejmek J., Solansky I., Podrazilová K., Srám R.J. The exposure of nonsmoking and smoking mothers to environmental tobacco smoke during different gestational phases and fetal growth. Environ Health Perspect 2002, 110:601-610.
15. Dollery C.T. Therapeutic drugs 1991, Churchill Livingstone, Edinburgh.
16. Eyler F.D., Behnke M., Wobie K., Garyan C.W., Tebbett I. Relative ability of biologic specimens and interviews to detect prenatal cocaine use. Neurotoxicol Teratol 2005, 27:677-687.
17. Eskenazi B., Castorina R. Association of prenatal maternal or postnatal child environmental tobacco smoke exposure and neurodevelopmental and behavioral problems in children. Environ Health Perspect 1999, 107:991-1000.
18. Esteban M., Castaño A. Non-invasive matrices in human biomonitoring: a review. Environ Int 2009, 35:438-449.
19. Falcon M., Pichini S., Joya J., Pujadas M., Sanchez A., Vall O., et al. Maternal hair testing for the assessment of fetal exposure to drug of abuse during early pregnancy: comparison with testing in placental and fetal remains. Forensic Sci Int 2012, 218:92-96.
20. Filser J. Ecotoxicology and ecosystems: relevance, restrictions, research Leeds. Basic Appl Ecol 2008, 9:333-336.
21. Finnegan L.P. Perinatal morbidity and mortality in substance using families: effects and intervention strategies. Bull Narc 1994, 46:19-43.
22. Finnegan L.P. Women, pregnancy and methadone. Heroin Addict Relat Clin Probl 2000, 2:1-8.
23. Fleming J.A., Byck R., Barash P.G. Pharmacology and therapeutic applications of cocaine. Anesthesiology 1990, 73:518-531.
24. Fríguls B., Joya X., García-Algar O., Pallás C.R., Vall O., Pichini S. A comprehensive review of assay methods to determine drugs in breast milk and the safety of breastfeeding when taking drugs. Anal Bioanal Chem 2010, 397:1157-1179.
25. Furara S.A., Carrick P., Armstrong D., Pairaudeau P., Pullan A.M., Lindow S.W. The outcome of pregnancy associated with amphetamine use. J Obstet Gynaecol 1999, 19:377-380.
26. Ganapathy V.V., Prasad P.D., Ganapathy M.E., Leibach F.H. Drugs of abuse and placental transport. Adv Drug Deliv Rev 1999, 38:99-110.
27. Gilmour M.I., Jaakkola M.S., London S.L., Nel A.E., Rogers C.A. How exposure to environmental tobacco smoke, outdoor air pollutants, and increased pollen burdens influences the incidence of asthma. Environ Health Perspect 2006, 114:627-633.
28. Glatz Z., Novakova S., Sterbova H. Analysis of thiocyanate in biological fluids by capillary zone electrophoresis. J Chromatogr A 2001, 916:273-277.
29. Gray T., Huestis M. Bioanalytical procedures for monitoring in utero drug exposure. Anal Bioanal Chem 2007, 388:1455-1465.
30. Gray T.R., Shakleya D.M., Huestis M.A. Quantification of nicotine, cotinine, trans-3'-hydroxycotinine, nornicotine and norcotinine in human meconium by liquid chromatography/tandem mass spectrometry. J Chromatogr B 2008, 863:107-114.
31. Gray T.R., Eiden R.D., Leonar K.E., Connors G.J., Shisler S., Huestis M.A. Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth. Clin Chem 2010, 56:1442-1450.
32. Gupta N., Balomajumder C., Agarwal V.K. Enzymatic mechanism and biochemistry for cyanide degradation: a review. J Hazard Mater 2010, 176:1-13.
33. Halstead A.C., Godolphin W., Lockitch G., Segal S. Timing of specimen collection is crucial in urine screening of drug dependent mothers and newborns. Clin Biochem 1988, 21:59-61.
34. Huestis M.A., Choo R.E. Drug abuse's smallest victims: in utero drug exposure. Forensic Sci Int 2002, 128:20-30.
35. Huestis M.A., Cone E.J. Alternative testing matrices. Drug abuse handbook 1998, 799-857. CRC Press, Boca Raton. 2nd ed. S.B. Karch (Ed.).
36. Jauniaux E., Burton G.J. Morphological and biological effects of maternal exposure to tobacco smoke on the feto-placental unit. Early Hum Dev 2007, 83:699-706.
37. Jedrychowski W., Flak E. Maternal smoking during pregnancy and postnatal exposure to environmental tobacco smoke as predisposition factors to acute respiratory infections. Environ Health Perspect 1997, 105:302-305.
38. Jenkins A.J. Pharmacokinetics: drug absorption, distribution, and elimination. Drug abuse handbook 2006, CRC Press, Boca Raton. 2nd ed. S.B. Karch (Ed.).
39. Jirovský D., Lemr K., Ševčík J., Smysl B., Stránský Z. Methamphetamine - properties and analytical methods of enantiomer determination. Forensic Sci Int 1998, 96:61-70.
40. Johnson W.W. Many drugs and phytochemicals can be activated to biological reactive intermediates. Curr Drug Metab 2008, 9:334-351.
41. Jones J. Nutrition, drugs and their interrelations. Pa Health 1974, 35:3.
42. Joya X., Pujadas M., Falcón M., Civit E., Garcia-Algar O., Vall O., et al. Gas chromatography-mass spectrometry assay for the simultaneous quantification of drugs of abuse in human placenta at 12th week of gestation. Forensic Sci Int 2010, 196:38-42.
43. Joya X., Gomez-Culebras M., Callejón A., Friguls B., Puig C., Ortigosa S., et al. Cocaine use during pregnancy assessed by hair analysis in a Canary Islands cohort. BMC Pregnancy Childbirth 2012, 12:1-8.
44. Karen G. Measurement of drugs in neonatal hair: a window to fetal exposure. Forensic Sci Int 1995, 70:77-82.
45. Kelly T., Gray T.R., Huestis M.A. Development and validation of a liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry method for simultaneous analysis of ten amphetamine-, methamphetamine- and 3,4-methylenedioxymethamphetamine-related (MDMA) analytes in human meconium. J Chromatogr B 2008, 867:194-204.
46. Kulaga V., Shor S., Koren G. Correlation between drugs of abuse and alcohol by hair analysis: parents at risk for having children with fetal alcohol spectrum disorder. Alcohol 2010, 44:615-621.
47. Larkby C., Day N. The effects of prenatal alcohol exposure. Alcohol Health Res World 1997, 21:192-198.
48. Lester B.M., El Sohly M., Wright L.L., Smeriglio V.L., Verter J., Bauer C.R., et al. The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report. Pediatrics 2001, 107:309-317.
49. Lester B.M., Andreozzi L., Appiah L. Substance use during pregnancy: time for policy to catch up with research. Harm Reduct J 2004, 1:5.
50. Lewis J.H. Clinical and medico-legal implications of drug testing for cannabis. NCPIC 2009, 7:1-6.
51. Llaquet H., Pichini S., Joya X., Papaseit E., Vall O., Klein J., et al. Biological matrices for the evaluation of exposure to environmental tobacco smoke during prenatal life and childhood. Anal Bioanal Chem 2010, 396:379-399.
52. Lozano J., García-Algar O., Vall O., De la Torre R., Scaravelli G., Pichini S. Biological matrices for the evaluation of in utero exposure to drugs of abuse. Ther Drug Monit 2007, 29:711-734.
53. Marchei E., Escuder D., Pallas C.R., Garcia-Algar O., Gómez A., Friguls B., et al. Simultaneous analysis of frequently used licit and illicit psychoactive drugs in breast milk by liquid chromatography tandem mass spectrometry. J Pharm Biomed Anal 2011, 55:309-316.
54. Mari F., Politi L., Bertol E. Nails of newborns in monitoring drug exposure during pregnancy. Forensic Sci Int 2008, 179:176-180.
55. Marx J.A., Hockberger R.S., Wall R.M., Adams J. Rosen's emergency medicine: concepts and clinical practice 2002, 2396-2400. CV Mosby, St. Louis. 5th ed.
56. Maurer H.H., Bickeboeller-Friedrich J., Kraemer T., Peters F.T. Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs ('Ecstasy'). Toxicol Lett 2000, 112-113:133-142.
57. Mbah A.K., Alio A.P., Fombo D.W., Bruder K., Dagne G., Salihu H.M. Association between cocaine abuse in pregnancy and placenta-associated syndromes using propensity score matching approach. Early Hum Dev 2012, 88:333-337.
58. Milerad J., Vege Å., Opdal S.H., Rognum T.O. Objective measurements of nicotine exposure in victims of sudden infant death syndrome and in other unexpected child deaths. J Pediatr 1998, 133:232-236.
59. Miller W.H., Hyatt M.C. Perinatal substance abuse. Am J Drug Alcohol Abuse 1992, 18:247-261.
60. Minnes S., Lang A., Singer L. Prenatal tobacco, marijuana, stimulant, and opiate exposure: outcomes and practice implications. Addict Sci Clin Pract 2011, 6:57-70.
61. Myren M., Mose T., Mathiesen L., Knudsen L.E. The human placenta - an alternative for studying fetal exposure. Toxicol In Vitro 2007, 21:1332-1340.
62. NCPIC: National Cannabis Prevention and Information Centre Cannabis use and pregnancy (13 June 2012). http://ncpic.org.au/ncpic/publications/factsheets/article/cannabis-use-and-reproduction.
63. NIAAA National Institute on Alcohol Abuse and Alcoholism No. 35; PH 371 January 1997 [13 June 2012]. http://pubs.niaaa.nih.gov/publications/aa35.htm.
64. Nickerson B., Colón I. Liquid-liquid and solid-phase extraction techniques. Sample preparation of pharmaceutical dosage forms 2011, 63-92. Springer, New York. B. Nickerson (Ed.).
65. Niemann R.A., Anderson D.L. Determination of iodide and thiocyanate in powdered milk and infant formula by on-line enrichment ion chromatography with photodiode array detection. J Chromatogr A 2008, 1200:193-197.
66. Ostrea E.M., Hernandez J.D., Bielawski D.M., Kan J.M., Leonardo G.M., Abela M.B., et al. Fatty acid ethyl esters in meconium: are they biomarkers of fetal alcohol exposure and effect?. Alcohol Clin Exp Res 2006, 30:1152-1159.
67. Otero C., Boles S., Young N.K., Dennis K. Methamphetamine: addiction, treatment, outcomes and implications 2004, U.S. Department of Health and Human Services, SAMHSA, Rockville, MD.
68. Page-Sharp M., Hale T.W., Hackett L.P., Kristensen J.H., Ilett K.F. Measurment of nicotine and cotynine in human milk by high-performance liquid chromatography with utlraviolet absorbance detection. J Chromatogr B 2003, 796:173-180.
69. Pappas R.S., Polzin G.M., Zhang L., Watson C.H., Paschal D.C., Ashley D.L. Cadmium, lead, and thallium in mainstream tobacco smoke particulate. Food Chem Toxicol 2006, 44:714-723.
70. Phibbs C.S., Bateman D.A., Schwartz R.M. The neonatal costs of maternal cocaine use. J Am Med Assoc 1991, 266:1521-1526.
71. Pichini S., Altieri I., Pellegrini M., Pacifici R., Zuccaro P. The analysis of nicotine in infants' hair for measuring exposure to environmental tobacco smoke. Forensic Sci Int 1997, 84:253-258.
72. Płotka J.M., Morrison C., Biziuk M. Common methods for the chiral determination of amphetamine and related compounds II. Capillary electrophoresis and nuclear magnetic resonance. Trends Anal Chem 2012, 31:23-37.
73. Pritchard J.D. Hydrogen cyanide: toxicological overview 2007, Heath Protecion Agency, [http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1202487078453, (11 June 2012)].
74. Raybuck S.A. Microbes and microbial enzymes for cyanide degradation. Biodegradation 1992, 3:3-18.
75. Richardson T. Pitfalls in forensic toxicology. Ann Clin Biochem 2000, 37:20-44.
76. Rogers J.M. Tobacco and pregnancy. Reprod Toxicol 2009, 28:152-160.
77. SAMHSA Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-41, HHS Publication No. (SMA) 11-4658 2011, Substance Abuse and Mental Health Services Administration, Rockville, MD, [http://www.samhsa.gov/data/NSDUH/2k10NSDUH/2k10Results.htm, (7 June 2012)].
78. Schütz H., Paine A., Erdmann F., Weiler G., Verhoff M.A. Immunoassays for drug screening in urine. Forensic Sci Med Pathol 2006, 2:75-83.
79. Shakleya D.M., Dams R., Choo R.E., Jones H., Huestis M.A. Simultaneous liquid chromatography-mass spectrometry quantification of urinary opiates, cocaine, and metabolites in opiate-dependent pregnant women in methadone-maintenance treatment. J Anal Toxicol 2010, 34:17-25.
80. Snow N.H. Solid-phase microextraction of drugs from biological matrices. J Chromatogr A 2000, 885:445-455.
81. Syme M.R., Paxton J.W., Keelan J.A. Drug transfer and metabolism by the human placenta. Clin Pharmacokinet 2004, 43:487-514.
82. Szumska M., Tyrpień K. Biomonitoring ksenobiotyków-wybrane zagadnienia 2011, MedPharm Polska, Wrocław.
83. Van der Aa E.M., Peereboom-Stegeman J.H., Noordhoek J., Gribnau F.W., Russel F.G. Mechanisms of drug transfer across the human placenta. Pharm World Sci 1998, 20:139-148.
84. Vinner E., Vignau J., Thibault D., Codaccioni X., Brassart C., Humbert L., et al. Neonatal hair analysis contribution to establishing a gestational drug exposure profile and predicting a withdrawal syndrome. Ther Drug Monit 2003, 25:421-432.
85. Vogel A. Neurodevelopment: cocaine wreaks subtle damage on developing brains. Science 1997, 278:38-39.
86. Yildiz D. Nicotine, its metabolism and an overview of its biological effects. Toxicon 2004, 43:619-632.
87. Zuckerman B., Frank D.A., Hingson R., Amaro H., Levenson S.M. Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med 1989, 320:762-768.